Search Results - "Hudson, Roger"

Refine Results
  1. 1
  2. 2

    Adolescent nicotine induces depressive and anxiogenic effects through ERK 1‐2 and Akt‐GSK‐3 pathways and neuronal dysregulation in the nucleus accumbens by Hudson, Roger, Green, Matthew, Wright, Daniel J., Renard, Justine, Jobson, Christina E.L., Jung, Tony, Rushlow, Walter, Laviolette, Steven R.

    Published in Addiction biology (01-03-2021)
    “…Long‐term tobacco dependence typically develops during adolescence and neurodevelopmental nicotine exposure is associated with affective disturbances that…”
    Get full text
    Journal Article
  3. 3

    2234-PUB: The Impact of a Community Paramedicine Program on Diabetes Outcomes and Health Care Utilization by EICKEN, MEREDITH, LEE, DEBBY, EWING, JOSEPH A., BUTLER, JOHN N., LUTZ, MARTIN E., SNOW, JENNIFER Z., HIPP, CANDICE, THOMAS, DARIN T., HEAD, CHARLES P., HUDSON-DOBBS, ROGER S., GREEN, VINCENT E., WEBER, SANDRA L.

    Published in Diabetes (New York, N.Y.) (01-06-2020)
    “…Background: As of 2017, South Carolina ranked 5th highest in the U.S. for percentage of adults with diabetes, which has negative health and cost implications…”
    Get full text
    Journal Article
  4. 4

    Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation by Hudson, Roger, Renard, Justine, Norris, Christopher, Rushlow, Walter J, Laviolette, Steven R

    Published in The Journal of neuroscience (30-10-2019)
    “…Evidence suggests that the phytocannabinoids Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) differentially regulate salience attribution and psychiatric…”
    Get full text
    Journal Article
  5. 5

    Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology by Hudson, Roger, Rushlow, Walter, Laviolette, Steven R.

    Published in Psychopharmacology (01-02-2018)
    “…Growing clinical and preclinical evidence suggests a potential role for the phytocannabinoid cannabidiol (CBD) as a pharmacotherapy for various…”
    Get full text
    Journal Article
  6. 6

    Functional interactions between cannabinoids, omega‐3 fatty acids, and peroxisome proliferator‐activated receptors: Implications for mental health pharmacotherapies by Jung, Tony, Hudson, Roger, Rushlow, Walter, Laviolette, Steven R.

    Published in The European journal of neuroscience (01-02-2022)
    “…Cannabis contains a plethora of phytochemical constituents with diverse neurobiological effects. Cannabidiol (CBD) is the main non‐psychotropic component found…”
    Get full text
    Journal Article
  7. 7

    The combination of escitalopram and aripiprazole: Investigation of psychomotor effects in rats by Hudson, Roger, Zhou, Yan, Leri, Francesco

    Published in Journal of psychopharmacology (Oxford) (01-12-2017)
    “…Pre-clinical and clinical evidence suggests that the antidepressant efficacy of the selective serotonin reuptake inhibitor escitalopram can be enhanced by the…”
    Get full text
    Journal Article
  8. 8

    Streptococcus devriesei sp. nov., from Equine Teeth by Collins, Matthew D., Lundström, Torbjörn, Welinder-Olsson, Christina, Hansson, Ingrid, Wattle, Ove, Hudson, Roger A., Falsen, Enevold

    Published in Systematic and applied microbiology (01-03-2004)
    “…Phenotypic and phylogenetic studies were performed on four unidentified Gram-positive staining, catalase-negative, α-hemolytic Streptococcus-like organisms…”
    Get full text
    Journal Article
  9. 9

    Anxiety and cognitive-related effects of [DELTA] .sup.9-tetrahydrocannabinol are differentially mediated through distinct GSK-3 vs. Akt-mTOR pathways in the nucleus accumbens of male rats by Hudson, Roger, Norris, Christopher, Szkudlarek, Hanna J, Khan, Dinat, Schmid, Susanne, Rushlow, Walter J, Laviolette, Steven R

    Published in Psychopharmacology (01-02-2022)
    “…Rationale [DELTA].sup.9-tetrahydrocannabinol (THC) is the primary psychoactive compound in cannabis and is responsible for cannabis-related neuropsychiatric…”
    Get full text
    Journal Article
  10. 10

    Effects of combined escitalopram and aripiprazole in rats: role of the 5-HT1a receptor by Lapointe, Thomas, Hudson, Roger, Daniels, Stephen, Melanson, Brett, Zhou, Yan, Leri, Francesco

    Published in Psychopharmacology (01-07-2019)
    “…Rationale Pre-clinical and clinical studies have suggested that the antidepressant efficacy of escitalopram (ESC) can be augmented by co-administration of…”
    Get full text
    Journal Article
  11. 11

    Deciphering midbrain mechanisms underlying prepulse inhibition of startle by Fulcher, Niveen, Azzopardi, Erin, De Oliveira, Cleusa, Hudson, Roger, Schormans, Ashley L., Zaman, Tariq, Allman, Brian L., Laviolette, Steven R., Schmid, Susanne

    Published in Progress in neurobiology (01-02-2020)
    “…•DREADD inhibition in PPTg and/or adjacent structure disrupts PPI upon i.p. CNO.•Startle latency increases following DREADD-induced inhibition of PPTg…”
    Get full text
    Journal Article
  12. 12

    Effects of combined escitalopram and aripiprazole in rats: role of the 5-HT.sub.1a receptor by Lapointe, Thomas, Hudson, Roger, Daniels, Stephen, Melanson, Brett, Zhou, Yan, Leri, Francesco

    Published in Psychopharmacology (01-07-2019)
    “…Rationale Pre-clinical and clinical studies have suggested that the antidepressant efficacy of escitalopram (ESC) can be augmented by co-administration of…”
    Get full text
    Journal Article
  13. 13

    Correction to: Effects of combined escitalopram and aripiprazole in rats: role of the 5-HT.sub.1a receptor by Lapointe, Thomas, Hudson, Roger, Daniels, Stephen, Melanson, Brett, Zhou, Yan, Leri, Francesco

    Published in Psychopharmacology (01-07-2019)
    “…After publication of this paper, the authors determined an error in Fig. 3. Below is the correct Fig. 3…”
    Get full text
    Journal Article
  14. 14

    Correction to: Effects of combined escitalopram and aripiprazole in rats: role of the 5-HT1a receptor by Lapointe, Thomas, Hudson, Roger, Daniels, Stephen, Melanson, Brett, Zhou, Yan, Leri, Francesco

    Published in Psychopharmacology (01-07-2019)
    “…After publication of this paper, the authors determined an error in Fig. 3. Below is the correct Fig. 3…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Anxiety and cognitive-related effects of Δ 9-tetrahydrocannabinol (THC) are differentially mediated through distinct GSK-3 vs. Akt-mTOR pathways in the nucleus accumbens of male rats by Hudson, Roger, Norris, Christopher, Szkudlarek, Hanna J., Khan, Dinat, Schmid, Susanne, Rushlow, Walter J., Laviolette, Steven R.

    Published in Psychopharmacology (01-02-2022)
    “…Rationale Δ 9 -tetrahydrocannabinol (THC) is the primary psychoactive compound in cannabis and is responsible for cannabis-related neuropsychiatric side…”
    Get full text
    Journal Article
  17. 17

    Fear Memory Recall Potentiates Opiate Reward Sensitivity through Dissociable Dopamine D1 versus D4 Receptor-Dependent Memory Mechanisms in the Prefrontal Cortex by Jing Li, Jing, Szkudlarek, Hanna, Renard, Justine, Hudson, Roger, Rushlow, Walter, Laviolette, Steven R

    Published in The Journal of neuroscience (09-05-2018)
    “…Disturbances in prefrontal cortical (PFC) dopamine (DA) transmission are well established features of psychiatric disorders involving pathological memory…”
    Get full text
    Journal Article
  18. 18

    THC and CBD produce divergent effects on perception and panic behaviours via distinct cortical molecular pathways by Szkudlarek, Hanna J., Rodríguez-Ruiz, Mar, Hudson, Roger, De Felice, Marta, Jung, Tony, Rushlow, Walter J., Laviolette, Steven R.

    “…•Intra-PFC infusion of THC and CBD lead to divergent behavioural and molecular profiles.•THC facilitates panic-like behaviour that can be prevented by…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Bupropion and naltrexone combination alters high fructose corn syrup self-administration and gene expression in rats by Levy, AnneMarie, Daniels, Stephen, Hudson, Roger, Horman, Thomas, Flynn, Amanda, Zhou, Yan, Leri, Francesco

    Published in Neuropharmacology (01-06-2018)
    “…Contrave® is an adjunct pharmacotherapy for obesity that contains bupropion (BUP) and naltrexone (NTX). To further explore the psychopharmacology of this drug…”
    Get full text
    Journal Article